Citigroup »

Eagle Pharmaceuticals shares owned by Citigroup

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by Citigroup

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.6M 1.0M 5.60
2024-03-31 $14k 2.7k 5.24
2023-12-31 $9.1k 1.7k 5.23
2023-09-30 $3.2k 203 15.77
2023-03-31 $210k 7.4k 28.37
2022-12-31 $987k 34k 29.23
2022-09-30 $1.5M 58k 26.43
2021-12-31 $1.8M 36k 50.93
2021-03-31 $1.8M 43k 41.73
2020-12-31 $340k 7.3k 46.54
2020-09-30 $312k 7.3k 42.48
2020-06-30 $826k 17k 47.96
2020-03-31 $610k 13k 45.95
2019-12-31 $457k 7.6k 60.06
2019-09-30 $1.1M 19k 56.62
2019-06-30 $284k 5.1k 55.66
2019-03-31 $301k 5.9k 50.53
2018-12-31 $4.5M 112k 40.29
2018-09-30 $3.3M 48k 69.31
2018-06-30 $2.8M 37k 75.66
2018-03-31 $2.5M 47k 53.44
2017-12-31 $2.4M 45k 53.41
2017-09-30 $2.9M 49k 59.64
2017-06-30 $2.7M 34k 78.89
2017-03-31 $1.6M 19k 82.95
2016-12-31 $5.9M 74k 79.34
2016-09-30 $559k 8.0k 70.04
2016-06-30 $12k 305 39.34
2015-12-31 $94k 1.1k 88.68
2015-09-30 $439k 5.9k 74.01
2015-06-30 $9.0k 111 81.08
2014-09-30 $0 14 0.00